PRESSURE BIOSCIENCES, INC. Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture
PRESSURE BIOSCIENCES, INC. reported Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture of $95.25 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-17.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture
us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation · last filed 2021-11-17
- PRESSURE BIOSCIENCES, INC. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2021-09-30 was $95.25K, a 43.14% increase year-over-year.
- PRESSURE BIOSCIENCES, INC. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2021-06-30 was $63.46K, a 2.88% decline year-over-year.
- PRESSURE BIOSCIENCES, INC. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2021-03-31 was $61.24K, a 74.67% decline year-over-year.
- PRESSURE BIOSCIENCES, INC. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2020-09-30 was $66.54K.
| Period end | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 3 month | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 6 month | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 9 month |
|---|---|---|---|
| 2021-09-30 | $95.25K 10-Q · filed 2021-11-17 | $158.71K derived: sum of 2 quarters · filed 2021-11-17 | $219.94K derived: sum of 3 quarters · filed 2021-11-17 |
| 2021-06-30 | $63.46K 10-Q · filed 2021-11-17 | $124.69K derived: sum of 2 quarters · filed 2021-11-17 | |
| 2021-03-31 | $61.24K 10-Q · filed 2021-11-17 | ||
| 2020-09-30 | $66.54K 10-Q · filed 2021-11-17 | $131.88K derived: sum of 2 quarters · filed 2021-11-17 | $373.65K derived: sum of 3 quarters · filed 2021-11-17 |
| 2020-06-30 | $65.34K 10-Q · filed 2021-11-17 | $307.11K derived: sum of 2 quarters · filed 2021-11-17 | |
| 2020-03-31 | $241.77K 10-Q · filed 2021-11-17 |